Impact of TGF-beta Receptor on Colon Cancer Prognosis
Author Information
Author(s): David Bacman, Susanne Merkel, Roland Croner, Thomas Papadopoulos, Wolfgang Brueckl, Arno Dimmler
Primary Institution: University of Erlangen-Nuremberg, Germany
Hypothesis
The study investigates the relationship between TGF-beta receptor expression in tumor-associated stroma and the prognosis of colon carcinoma.
Conclusion
The study found that lower expression of TGF-beta receptor 2 in tumor-associated stroma is associated with worse cancer-related survival in colon cancer patients.
Supporting Evidence
- High-grade tumors showed higher rates of tumor-associated macrophages.
- Lower expression of TGF-beta1 was found in high-grade tumors.
- Loss of nuclear Smad4 expression was associated with lymph node metastasis.
- Decreased TGF-beta receptor expression in stroma correlated with shorter survival.
Takeaway
This study shows that the way cancer cells interact with their environment, especially with certain proteins, can affect how well patients do after treatment.
Methodology
The study used tissue microarrays from 310 colon carcinoma patients to analyze tumor-associated macrophages and TGF-beta signaling components.
Potential Biases
Potential biases may arise from the retrospective nature of the study and selection criteria for included patients.
Limitations
The study is retrospective and may not account for all confounding factors affecting prognosis.
Participant Demographics
The cohort included 310 patients, with 61% male and a median age of 64 years.
Statistical Information
P-Value
p<0.001 for TAMs in high-grade tumors
Confidence Interval
95% CI 1.2–3.8
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website